{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:09Z","timestamp":1792782789873,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck","id":[{"id":"https:\/\/ror.org\/054pv6659","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>We report the first case in Austria of cardiac arrest associated with isolated kratom intoxication in a\u00a0young man, supported by toxicological blood analysis revealing markedly elevated mitragynine concentrations. Despite its perception as a\u00a0low-risk substance, kratom can cause severe and potentially fatal adverse effects. This case highlights the need for increased clinical awareness, public education and further investigation of the cardiovascular safety of mitragynine.<\/jats:p>","DOI":"10.1007\/s00508-026-02826-5","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:23:28Z","timestamp":1790187808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sudden cardiac arrest in a\u00a0young healthy man following kratom tea consumption: a\u00a0case report and brief literature review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6323-2154","authenticated-orcid":false,"given":"Jonas","family":"Dunz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Kr\u00f6sbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Unterpertinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Putzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"1","key":"2826_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/add.15082","volume":"116","author":"J Schimmel","year":"2021","unstructured":"Schimmel\u00a0J, Amioka\u00a0E, Rockhill\u00a0K, et\u00a0al. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a\u00a0cross-sectional study. Addiction. 2021;116(1):176\u201381. https:\/\/doi.org\/10.1111\/add.15082.","journal-title":"Addiction"},{"issue":"11","key":"2826_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.15585\/mmwr.mm7511a1","volume":"75","author":"EB Towers","year":"2026","unstructured":"Towers\u00a0EB, Thomas\u00a0YT, Holstege\u00a0CP, et\u00a0al. Increases in Kratom-Related Reports to Poison Centers - National Poison Data System, United States, 2015\u20132025. MMWR Morb Mortal Wkly Rep. 2026;75(11):139\u201345. https:\/\/doi.org\/10.15585\/mmwr.mm7511a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2826_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/10550887.2020.1788914","volume":"38","author":"JR Covvey","year":"2020","unstructured":"Covvey\u00a0JR, Vogel\u00a0SM, Peckham\u00a0AM, et\u00a0al. Prevalence and characteristics of self-reported kratom use in a representative US general population sample. J\u00a0Addict Dis. 2020;38(4):506\u201313. https:\/\/doi.org\/10.1080\/10550887.2020.1788914.","journal-title":"J Addict Dis"},{"key":"2826_CR4","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2022.e200415","volume":"20","author":"G Papadi","year":"2022","unstructured":"Papadi\u00a0G, Bakhiya\u00a0N, Hirsch-Ernst\u00a0I. Assessment of the possible health risks associated with the consumption of botanical preparations of Mitragyna speciosa (kratom). EFSA J. 2022;20:e200415. https:\/\/doi.org\/10.2903\/j.efsa.2022.e200415.","journal-title":"EFSA J"},{"key":"2826_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2023.107054","volume":"225","author":"D Peran","year":"2023","unstructured":"Peran\u00a0D, Stern\u00a0M, Cernohorsky\u00a0P, et\u00a0al. Mitragyna speciosa (Kratom) poisoning: Findings from ten cases. Toxicon X. 2023;225:107054. https:\/\/doi.org\/10.1016\/j.toxicon.2023.107054.","journal-title":"Toxicon"},{"issue":"12","key":"2826_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7556\/jaoa.2016.156","volume":"116","author":"WC Prozialeck","year":"2016","unstructured":"Prozialeck\u00a0WC. Update on the Pharmacology and Legal Status of Kratom. Journal of Osteopathic Medicine. 2016;116(12):802\u20139. https:\/\/doi.org\/10.7556\/jaoa.2016.156.","journal-title":"Journal of Osteopathic Medicine"},{"issue":"12","key":"2826_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2165\/11596830-000000000-00000","volume":"25","author":"J Ward","year":"2011","unstructured":"Ward\u00a0J, Rosenbaum\u00a0C, Hernon\u00a0C, et\u00a0al. Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy? CNS Drugs. 2011;25(12):999\u20131007. https:\/\/doi.org\/10.2165\/11596830-000000000-00000.","journal-title":"CNS Drugs"},{"issue":"9","key":"2826_CR8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1177\/0269881119862530","volume":"33","author":"JM Corkery","year":"2019","unstructured":"Corkery\u00a0JM, Streete\u00a0P, Claridge\u00a0H, et\u00a0al. Characteristics of deaths associated with kratom use. J\u00a0Psychopharmacol. 2019;33(9):1102\u201323. https:\/\/doi.org\/10.1177\/0269881119862530.","journal-title":"J Psychopharmacol"},{"issue":"7","key":"2826_CR9","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1080\/07448481.2022.2112584","volume":"72","author":"MC Parent","year":"2024","unstructured":"Parent\u00a0MC, Woznicki\u00a0NW, Yang\u00a0J. Demographic and behavioral factors associated with kratom use among U.S. college students. J\u00a0Am Coll Health. 2024;72(7):1983\u20137. https:\/\/doi.org\/10.1080\/07448481.2022.2112584.","journal-title":"J Am Coll Health"},{"key":"2826_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebcr.2018.04.002","volume":"10","author":"WO Tatum","year":"2018","unstructured":"Tatum\u00a0WO, Hasan\u00a0TF, Coonan\u00a0EE, et\u00a0al. Recurrent seizures from chronic kratom use, an atypical herbal opioid. Epilepsy Behav Rep. 2018;10:18\u201320. https:\/\/doi.org\/10.1016\/j.ebcr.2018.04.002.","journal-title":"Epilepsy Behav Case Rep"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-026-02826-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:23:29Z","timestamp":1790187809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-026-02826-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":10,"alternative-id":["2826"],"URL":"https:\/\/doi.org\/10.1007\/s00508-026-02826-5","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Dunz, M.\u00a0Janes, A.\u00a0Kr\u00f6sbacher, R.\u00a0Unterpertinger and G.\u00a0Putzer declare that they have no competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from the patient.","order":2,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was not required for this case report.","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}